Kyverna Therapeutics, Inc.
KYTX
$1.84
$0.0050.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 285.98M | 321.59M | 346.24M | 369.79M | 57.54M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.62M | 3.79M | 2.59M | 5.69M | 3.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 290.60M | 325.37M | 348.82M | 375.49M | 60.66M |
|
|
|||||
| Total Current Assets | 290.60M | 325.37M | 348.82M | 375.49M | 60.66M |
| Net Property, Plant & Equipment | 10.66M | 11.38M | 12.51M | 12.75M | 10.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.39M | 2.44M | 1.79M | 1.74M | 3.92M |
| Total Assets | 304.65M | 339.20M | 363.12M | 389.98M | 75.20M |
|
|
|||||
| Total Accounts Payable | 4.62M | 9.93M | 4.86M | 7.45M | 4.36M |
| Total Accrued Expenses | 11.13M | 17.12M | 14.75M | 10.70M | 9.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.94M | 3.93M | 3.87M | 3.72M | 2.92M |
| Total Finance Division Other Current Liabilities | 14.06M | -- | -- | -- | 3.52M |
| Total Other Current Liabilities | 14.06M | -- | -- | -- | 3.52M |
| Total Current Liabilities | 33.76M | 30.99M | 23.48M | 21.87M | 19.86M |
|
|
|||||
| Total Current Liabilities | 33.76M | 30.99M | 23.48M | 21.87M | 19.86M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.30M | 5.21M | 6.13M | 7.13M | 6.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 296.00K | -- | -- | -- |
| Total Liabilities | 38.06M | 36.49M | 29.61M | 28.99M | 26.02M |
|
|
|||||
| Common Stock & APIC | 530.00M | 528.59M | 525.09M | 523.73M | 4.64M |
| Retained Earnings | -263.52M | -226.03M | -191.54M | -162.74M | -136.04M |
| Treasury Stock & Other | 105.00K | 153.00K | -37.00K | -1.00K | 4.00K |
| Total Common Equity | 266.59M | 302.71M | 333.51M | 360.99M | -131.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 180.57M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 180.57M |
|
|
|||||
| Total Common Equity | 266.59M | 302.71M | 333.51M | 360.99M | -131.40M |
| Total Preferred Equity | -- | -- | -- | -- | 180.57M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 266.59M | 302.71M | 333.51M | 360.99M | 49.18M |
|
|
|||||